PubMed:29194348 / 1233-1396 JSONTXT

Annnotations TAB JSON ListView MergeView

    GoldHamster

    {"project":"GoldHamster","denotations":[{"id":"T250","span":{"begin":8,"end":22},"obj":"C503204"},{"id":"T251","span":{"begin":8,"end":22},"obj":"C503204"},{"id":"T252","span":{"begin":27,"end":44},"obj":"C477718"},{"id":"T253","span":{"begin":27,"end":44},"obj":"C477718"},{"id":"T255","span":{"begin":97,"end":108},"obj":"D005959"}],"text":", while sargachromenol and sargaquinoic acid showed dose-dependent inhibitory activity against α-glucosidase (IC50 42.41 ± 3.09 and 96.17 ± 3.48 µM, respectively)."}

    PubMed_ArguminSci

    {"project":"PubMed_ArguminSci","denotations":[{"id":"T10","span":{"begin":0,"end":163},"obj":"DRI_Outcome"}],"text":", while sargachromenol and sargaquinoic acid showed dose-dependent inhibitory activity against α-glucosidase (IC50 42.41 ± 3.09 and 96.17 ± 3.48 µM, respectively)."}

    Goldhamster2_Cellosaurus

    {"project":"Goldhamster2_Cellosaurus","denotations":[{"id":"T16","span":{"begin":78,"end":86},"obj":"CVCL_C410|Hybridoma|Mus musculus"}],"text":", while sargachromenol and sargaquinoic acid showed dose-dependent inhibitory activity against α-glucosidase (IC50 42.41 ± 3.09 and 96.17 ± 3.48 µM, respectively)."}